Shanghai Xin Huanghe Pharmaceutical Co., Ltd.

This trial tests whether CP006, an investigational inhaler combining three medications (budesonide, formoterol, and umeclidinium), improves lung function in adults with asthma better than a standard two-drug inhaler. Participants take either a high or low dose of CP006 or the com…

This Phase 3 trial tests whether a new budesonide/formoterol dry powder inhaler works as well as the established Symbicort Turbuhaler in adults with asthma. About 338 participants will take either the test inhaler or Symbicort twice daily for six weeks. Researchers will measure c…

This trial tests whether a new formulation of budesonide and formoterol inhalation powder delivers the same amount of medication into the body as the approved Symbicort Turbuhaler. Healthy adults aged 18 to 45 will receive a single dose of each inhaler in random order, with a 4-d…